Member Info for EyeGuy

Rising fast now . Keeps going NT to buy

Pretty disgusting trolling on here and twitter. These trolls will sell their own granny to make money on other people’s fear. Don’t forgot as they convince you to sell they will be buying. They aren’t trying to save you. They are here to screw you

The experts have said how good the news is.
But bulletin board unqualified trolls disagree
Who to believe lol

Close blue. Just you watch

Added at 0.28p. Book should switch later imo.

£2 million cash

Funny watching the trolls desperately trying to bash this with false information. Lmao. See you all at 40p

Goldsmith- wrong.
201 used for Covid
301 being trialled by Japanese pharma
401- black cat funding source etc

VAL301 news should be coming for endometriosis with the Japanese global pharma. Good news is the safety profile is applicable from the 201 study.
Endometriosis market worth $2 billion annually
See you all over 40p again later

Got more 32.5. Easy flip for 40% imo.

Endometriosis market $2 billion per year
VAL 301 being trialled by global pharma.
Now safety profile of 201 has been met, can be applied to 301 too. Makes chance of something happening soon much greater imo

Bankfool- some big money came in sub 30p hence it dropped to get those orders in. Should be a +25% day today imo. 42p close imo

301 and 201
Typo

They were very good and that comes from people in the field. Large orders filled now below 30p.
42p close tomorrow imo.
Safety profile makes 301 and 401 even more valuable now

BB - ;-)

BB- you haven’t seen the post from Adam Hargreaves then ?
The primary aims of the study encompassed the assessment of the safety and tolerability of VAL201. This study has documented that VAL201 has demonstrated a good safety and tolerability profile. The lack of a MTD should not be mis-interpreted as not fulfilling the requirements of delineating the useable safety range of the drug (as some have alluded to this morning). It looks to be very kind in these respects, which is great news for patients. This is what we want; drugs that work and drugs that also don’t destroy the soul with side-effects. God knows, in oncology we need them

Vicjain- Suzanne dilly tweeted the safety profile is applicable to 301 and 401, or words to that effect.
The Japanese global pharma are testing VAL301 at their expense and now a large part of that (ie safety profile) has passed with flying colors.
So all to play for and should recover very quick

I’ve Called this pretty well so far. Note nick slater whacked some big buy orders in sub 30p. Dropped for that imo. Tomorrow it goes again. 42p would be my guess at close. Possibly fear of a placing too, but looks unlikely now as they have £2 million.

This won’t be down 50% tomorrow.
Hard to buy sub 30p. Tomorrow should be about 42p ish imo.

Right on cue- British bulldog with the warnings.
You warned me at 3.7p. I ignored you.
And I’ll ignore you again.